Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Autism is Scopus-indexed (Q1, CiteScore 8.6), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2040-2392Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Psychiatry and Mental Health | 52 / 580 | 91st | Q1 |
| Developmental Neuroscience | 4 / 38 | 90th | Q1 |
| Developmental Biology | 13 / 78 | 83rd | Q1 |
| Molecular Biology | 93 / 414 | 77th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 8.6.
Molecular Autism is Q1 in Psychiatry and Mental Health (rank 52 of 580), Q1 in Developmental Neuroscience (rank 4 of 38) and Q1 in Developmental Biology (rank 13 of 78), by CiteScore 2025. It is ranked in 4 subject areas in all.
Molecular Autism is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.6, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.788, quartile Q1, with an H-index of 93.
The publisher lists an article processing charge of about US$3,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Autism is published by BioMed Central Ltd. Its ISSN is 2040-2392.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Molecular Autism has an h-index of 116 and a 2-year mean of 5.56 citations per paper (OpenAlex). Its Scopus CiteScore is 8.6, quartile Q1. On 2-year citations it ranks #31 of 570 Scopus journals in Psychiatry and Mental Health.
Molecular Autism published 65 papers in 2025; its busiest recent year was 2020 with 99. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (31.8%), United Kingdom (14.1%) and China (13.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.